Proton-beam centers sprout despite evidence drought
Skip to main content
MDHC_Logotype_white
Subscribe
  • My Account
  • Login
  • Subscribe
  • News
    • This Week's News
    • COVID-19
    • Providers
    • Insurance
    • Government
    • Finance
    • Technology
    • Safety & Quality
    • People
    • Regional News
    • Digital Edition
    • Cigna's MDLive acquisition could foster virtual-first plan development, analysts say
      As COVID surged, vaccines came too late for at least 400 medical workers
      Why AstraZeneca and J&J's vaccines, in use elsewhere, are still on hold in America
      Lawmakers probe if Cuomo's policy fueled nursing home deaths
    • As COVID surged, vaccines came too late for at least 400 medical workers
      Why AstraZeneca and J&J's vaccines, in use elsewhere, are still on hold in America
      Lawmakers probe if Cuomo's policy fueled nursing home deaths
      0928p1_nysna Rally 2_Dave Sanders_i.jpg
      New York State Nurses Association report finds over 26,000 nurse understaffing complaints filed in 2019 and 2020
    • Dr. Imran Andrabi
      Q&A: ThedaCare CEO says lessons from COVID-19 will inform new approaches to population health management
      The Check Up: Dr. Imran Andrabi
      The Check Up: Dr. Imran Andrabi of ThedaCare
      Hospitals confront water shortages in winter storm aftermath
      beaumont-hospital-royal-oak_i_i_i.jpg
      Beaumont says nearly 2,000 second-shot vaccinations canceled due to vaccine shortage
    • High MLRs inspire insurers to focus on quality improvements
      Blue Cross and Blue Shield of Oklahoma, OU Health Physicians mired in contract dispute
      Beyond the Byline: Insurers are betting on virtual-first plans as COVID-19 shifts care pathways
      Beyond the Byline: Insurers are betting on virtual-first plans as COVID-19 shifts care pathways - Transcript
    • Why AstraZeneca and J&J's vaccines, in use elsewhere, are still on hold in America
      Lawmakers probe if Cuomo's policy fueled nursing home deaths
      Questions arise about public disclosure of wasted vaccines
      Becerra confirmation starting to look more likely
    • Genomics firms taking advantage of SPACs trend to go public faster
      COVID-19 could dent hospital revenue by at least $53 billion in 2021, AHA says
      deloitte GDP image chart graph going up
      Sponsored Content Provided By Deloitte
      Breaking the cost curve
      Dennis Dahlen
      Health systems aren't rushing to cut back on financial liquidity
    • Teladoc reports $383.3M in fourth-quarter revenue, up 145%
      man and woman looking at ipad wearing face masks stock image
      Sponsored Content Provided By Surescripts
      Improvements to benefits data can enhance ePrescribing and the patient experience
      Oscar Health's $1B IPO sets the stage for more health tech exits in 2021
      A map of the U.S. with images of the coronavirus.
      The digital divide becomes a new social determinant of health
    • Why AstraZeneca and J&J's vaccines, in use elsewhere, are still on hold in America
      COVID vaccine websites violate disability laws, create inequity for the blind
      Walgreens to sell Labcorp COVID-19 PCR home collection kits over-the-counter
      angela karpf headshot
      Sponsored Content Provided By B. Braun
      Making patient safety a policy priority
    • Michael Jordan, Novant team up to address health equity
      Former Ascension CEO, the first to lead the health system, passes away
      Biden's pick to head CMS would be first Black woman to hold post
      RAKESH SURI MD_i.jpg
      Cleveland Clinic creates president of international operations position
    • Midwest
    • Northeast
    • South
    • West
  • Insights
    • ACA 10 Years After
    • Best Practices
    • Special Reports
    • Innovations
    • The Affordable Care Act after 10 years
    • Dr. John Fischer
      Patient-reported outcomes tool for hernia surgery helps physicians improve care
      New care model helps primary-care practices treat obesity
      doctor with patient
      COVID-19 treatment protocol developed in the field helps patients recover
      Rachel Wyatt
      Project to curb pressure injuries in hospitals shows promise
    • What's next for on-demand telehealth companies?
      A map of the U.S. with images of the coronavirus.
      The digital divide becomes a new social determinant of health
      A CalOptima PACE vaccination clinic.
      Will COVID-19 be the catalyst for creating a more sustainable healthcare system?
      Ascension’s St. Mary’s Hospital Surgery Center at Towne Centre and Allegheny Health Network’s Bethel Park surgery center
      Hospitals see opportunity, risk in ambulatory surgery centers
    • Dr. Daniel Hall
      UPMC pilots machine learning, telehealth to inform patient transfers
      A woman being recorded using her inhaler on a smartphone.
      Digital check-ins, connected inhalers help control asthma
      A phone screen showing the question, "Mary we hope this information was helpful and we'd like to keep guiding you. Are you interested in knowing when it's your turn to receive the vaccine?"
      Chatbots, texting campaigns help manage influx of COVID vax questions
      A woman with a wearable sensor talking to her provider.
      Wearable sensors help diagnose heart rhythm problems in West Virginia
  • Transformation
    • Patients
    • Operations
    • Care Delivery
    • Payment
    • What's next for on-demand telehealth companies?
      Rising prescription copays drop adherence, spike mortality, research shows
      Dr. John Fischer
      Patient-reported outcomes tool for hernia surgery helps physicians improve care
      Highmark Health inks six-year cloud, tech deal with Google
    • Hospitals' Medicare billing practices suggest upcoding, OIG says
      California hospitals prepare ethical protocol to prioritize lifesaving care
      Amazon, JPMorgan Chase, Berkshire Hathaway disband Haven
      Digital pathways poised to reshape healthcare continuum in 2021
    • Dr. Daniel Hall
      UPMC pilots machine learning, telehealth to inform patient transfers
      A woman being recorded using her inhaler on a smartphone.
      Digital check-ins, connected inhalers help control asthma
      Humana partners with in-home provider for 24/7 care
      A phone screen showing the question, "Mary we hope this information was helpful and we'd like to keep guiding you. Are you interested in knowing when it's your turn to receive the vaccine?"
      Chatbots, texting campaigns help manage influx of COVID vax questions
    • Coordinated payment policies could speed transition to value, experts say
      CMMI's geographic direct contracting model needs an overhaul, experts say
      Hospitals fight UnitedHealthcare policies over lab test, specialty drug payments
      Cigna eliminates prior authorization for coronary CT scans
  • Data/Lists
    • Rankings/Lists
    • Interactive Databases
    • Data Points
    • Health Systems Financials
      Executive Compensation
      Physician Compensation
  • Op-Ed
    • Bold Moves
    • Breaking Bias
    • Commentaries
    • Letters
    • Vital Signs Blog
    • From the Editor
    • Dr. Alan Kaplan
      The risks, rewards of taking organizations 'where they haven’t gone before'
      Wellstar CEO calls adapting for the pandemic her bold move
      Howard P. Kern
      Recognizing the value of telehealth in its infancy
      Dr. Stephen Markovich
      A bold move helped take him from family doctor to OhioHealth CEO
    • Dr. Stephen Markovich
      Making sure we're aligned along the path to achieving inclusion
      Barry Ostrowsky
      Ending racism is a journey taken together; the starting point must be now
      Laura Lee Hall and Gary Puckrein
      Increased flu vaccination has never been more important for communities of color
      John Daniels Jr.
      Health equity: Making the journey from buzzword to reality
    • In-person visitation must be part of the national COVID-19 response
      We've lost so much to the pandemic, but we've also made gains that will endure
      Medical groups key to meeting president's vaccine pledge
      We need a better social care referral loop, but it requires technology as well as the human touch
    • Letters: Eliminating bias in healthcare needs to be ‘deliberate and organic’
      Letters: Maybe dropping out of ACOs is a good thing for patients
      Letters: White House and Congress share blame for lack of national COVID strategy
      Letters: VA making strides to improve state veterans home inspections
    • Sponsored Content Provided By Optum
      How blockchain could ease frustration with the payment process
      Sponsored Content Provided By Optum
      Three steps to better data-sharing for payer and provider CIOs
      Sponsored Content Provided By Optum
      Reduce total cost of care: 6 reasons why providers and payers should tackle the challenge together
      Sponsored Content Provided By Optum
      Why CIOs went from back-office operators to mission-critical innovators
  • Awards
    • Award Programs
    • Nominate
    • Previous Award Programs
    • Other Award Programs
    • Best Places to Work in Healthcare Logo for Navigation
      Nominations Open - Best Places to Work in Healthcare
      Nominations Open - 50 Most Influential Clinical Executives
    • 100 Most Influential People
    • 50 Most Influential Clinical Executives
    • Best Places to Work in Healthcare
    • Health Care Hall of Fame
    • Healthcare Marketing Impact Awards
    • Top 25 Emerging Leaders
    • Top 25 Innovators
    • Minorities in Healthcare
      • - Luminaries
      • - Top 25 Minority Leaders
      • - Minorities to Watch
    • Women in Healthcare
      • - Luminaries
      • - Top 25 Women Leaders
      • - Women to Watch
    • Excellence in Nursing Awards
    • Design Awards
    • Top 25 COOs in Healthcare
    • 100 Top Hospitals
    • ACHE Awards
  • Events
    • Conferences
    • Galas
    • Webinars
    • COVID-19 Event Tracker
    • podium march webinar logo lockup
      Sponsored Content Provided By Podium
      Webinar: Critical Touchpoints for Every Patient’s Journey — How Technology Plays an Important Role
      scp health logo lockup march 2021
      Sponsored Content Provided By SCP Health
      Webinar: COVID’s call to action — Reset for success in 2021
    • Women Leaders in Healthcare Conference
    • Social Determinants of Health Symposium
    • Healthcare Transformation Summit
    • Leadership Symposium
    • Virtual Briefings
      • - Hospital of the Future
      • - Mental Health
      • - Patient Safety & Quality
      • - Strategic Marketing
      • - Virtual Health
      • - Workplace of the Future
    • Best Places to Work Awards Gala
    • Health Care Hall of Fame Gala
    • Top 25 Minority Leaders Gala
    • Top 25 Women Leaders Gala
  • Listen
    • Podcast - Next Up
    • Podcast - Beyond the Byline
    • Sponsored Podcast - Healthcare Insider
    • Video Series - The Check Up
    • Sponsored Video Series - One on One
    • Next Up Podcast: Educating patients on the COVID-19 vaccine with Tanya Andreadis
      Dr. Joseph Cacchione
      Next Up Podcast: Educating patients on the COVID-19 vaccine with Dr. Joseph Cacchione
      Dr. Karen DeSalvo
      Next Up Podcast: What to expect with telehealth and healthcare technology in the next four years
      Carter Dredge
      Next Up Podcast: Ready, set, innovate! Innovation and disruption in healthcare
    • Beyond the Byline: Insurers are betting on virtual-first plans as COVID-19 shifts care pathways
      Beyond the Byline: How residents' stories shape our coverage of the vaccination rollout in nursing homes
      Beyond the Byline: Regulators aim to boost value push with fraud and abuse law updates
      An older man wearing a mask receiving a vaccine.
      Beyond the Byline: Verifying information on the chaotic COVID-19 vaccine rollout
    • Outreach during COVID-19
      Leading intention promote diversity and inclusion
      Introducing Healthcare Insider Podcast
    • The Check Up: Dr. Imran Andrabi
      The Check Up: Dr. Imran Andrabi of ThedaCare
      The Check Up: Tanya Blackmon
      The Check Up: Tanya Blackmon of Novant Health
      The Check Up: Dr. Patrick Hwu
      The Check Up: Dr. Patrick Hwu of the Moffitt Cancer Center
      The Check Up: Suresh Gunasekaran
      The Check Up: Suresh Gunasekaran of the University of Iowa Hospitals & Clinics
    • ivana naeymi-rad one on one intelligent medical objects
      Video: Ivana Naeymi Rad of Intelligent Medical Objects
  • MORE +
    • Advertise
    • Media Kit
    • Newsletters
    • Jobs
    • People on the Move
    • Reprints & Licensing
MENU
Breadcrumb
  1. Home
  2. Government
April 12, 2014 01:00 AM

Proton-beam centers sprout despite evidence drought

Jaimy Lee
  • Tweet
  • Share
  • Share
  • Email
  • More
    Print
    The Kling Proton Therapy Center inSt. Louis installed the first Mevion S250 proton-beam therapy system. The system received clearance from the Food and Drug Administration in 2012.

    (This article has been updated with a correction.)

    Widespread construction of expensive proton-beam therapy centers is galloping ahead, despite warnings from insurers and policy experts who decry the lack of evidence proving that the costly treatment produces better outcomes in prostate cancer patients, its most frequent use.

    At least a dozen new facilities, which can cost more than $200 million each to build, are on the drawing board or under construction. Their completion would nearly double the number of proton centers in the U.S. Advocates of the technology say proton-beam therapy spares healthy tissue and can improve a patient's quality of life and overall outcomes. But the procedure can cost twice as much as traditional radiation treatment. Critics say that financial incentives may be encouraging hospitals and companies to invest in the facilities and push patients toward proton-beam therapy when less costly and equally effective treatments are readily available.

    “I view proton-beam therapy as ground zero to look at whether we're going to bend the cost curve,” said Amitabh Chandra, director of health policy research at the Harvard Kennedy School of Government. “It's very hard to spot waste in healthcare. Proton therapy is an example of waste you can spot right away.”

    Although Loma Linda (Calif.) University Medical Center opened the nation's first proton center in 1990, only in the past decade has it become more widely used for treating prostate cancer, as well as cancers of the lung, breast, head and neck, and pediatric cancers.

    Hospitals and proton centers, well aware of skepticism, are seeking to research and quantify the benefits of proton-beam use in prostate cancer patients. Proponents say the technology eradicates tumors more effectively and has fewer side effects such as incontinence or impotence, which frequently affect men receiving more traditional radiation therapies. To prove those benefits, these providers are participating in prospective clinical trials, developing registries and conducting research to address questions from patients and insurers about the quality and costs of proton-beam therapy.

    “Part of the challenge is that there hasn't been a lot of clinical evidence to promote proton therapy,” said Stuart Klein, executive director of the University of Florida Proton Therapy Institute in Jacksonville, which opened in 2006. “As time goes on, the level of clinical evidence is going to increase.”

    Insurers, policy experts and professional societies in recent years have questioned whether proton-beam therapy is the most cost-effective treatment for prostate cancer.

    In addition, clinical practice is moving away from aggressive strategies to identify and treat prostate cancer. Fewer doctors are recommending prostate-specific antigen screening and more men are choosing active surveillance when the cancer is identified.

    Prostate cancer will be diagnosed in 233,000 men in 2014 and kill nearly 30,000, according to the American Cancer Society. Business plans behind many of the newer proton-beam facilities have assumed there will be a steady flow of prostate cancer patients, but that hasn't turned out to be the case.

    For example, the ProCure Proton Therapy Center, a joint venture between CentraState Medical Center in Freehold, N.J., and Somerset, N.J.-based ProCure, a private-equity operator of three proton centers, has struggled to bring in enough patients.

    The center, which opened in 2012, had projected it would treat up to 80% of its patients for prostate cancer. But this year it expects only 25% of its patients to come in for prostate cancer treatment.

    Concern about flagging volumes led the center to form a partnership with the New York Proton Regional Center, a group of New York-based hospitals that plan to open their own proton center in the next three years. As part of the agreement, physicians from Memorial Sloan-Kettering Cancer Center, New York University Langone Medical Center and three other hospitals will have staff privileges at the Somerset facility.

    Other centers also are forming regional partnerships, and some are purchasing less costly systems. Several years ago, Scripps Health and the University of California San Diego Health System announced plans to open proton centers. But when the Scripps Proton Therapy Center opened in February, UC San Diego Health System and Rady Children's Hospital, also in San Diego, had signed on as affiliate partners. “It doesn't make a lot of sense duplicating this expensive resource,” said Chris Van Gorder, president and CEO of Scripps Health.

    The $220 million center is owned by Advanced Particle Therapy, a San Diego-based developer of proton centers. Scripps provides clinical management and oversees medical services. Advanced Particle Therapy, which partnered with Varian Medical Systems, one of several manufacturers of proton-therapy equipment in the U.S., is developing three other centers in partnership with other hospitals. Varian provided a $115 million loan to the Scripps center and will receive 4% of gross revenue for 35 years, according to securities filings.

    The center plans to treat 2,000 patients a year, with a significant percentage of its volumes expected to come from prostate-cancer patients.

    While most experts are quick to acknowledge that proton-beam therapy is beneficial for pediatric patients and those with cancerous tumors affecting the head and neck, those cases are quite rare and would not justify the cost of construction. It's the use of protons for early-stage prostate cancer that has been scrutinized most closely by insurers.

    MH Takeaways

    Hospitals investing in proton-beam radiation therapy centers are gambling on clinical evidence that is still years away to justify their plunge into the expensive technology.

    Blue Shield of California and Aetna revised their coverage policies in 2013 around the latest indications, declining to cover proton-beam therapy as a treatment for localized prostate cancer. Cigna this year reaffirmed its position that proton-beam therapy is not considered medically necessary to treat prostate cancer and will not be covered.

    An Aetna spokeswoman said the company's policy revision followed a 2013 statement from the American Society for Radiation Oncology that said the effectiveness of proton-beam therapy for localized prostate cancer when compared with other treatment options was unclear, and that it should not be routinely used on patients. Aetna said it does support allowing coverage when providers capture evidence from patients by participating in clinical trials, or when they enter results into registries to determine the treatment's long-term outcomes.

    Research to date has questioned whether proton-beam therapy leads to better outcomes for prostate-cancer patients. A 2012 study published in the Journal of the National Cancer Institute found proton therapy led to a modest reduction in side effects for the first six months after treatment, but found no differences when comparing the treatment to traditional intensity modulated radiotherapy after one year. The proton therapy cost 70% more than traditional treatment, the study noted.

    “The relative reimbursement of new medical technologies needs to be considered carefully so that physicians and hospitals do not have a financial incentive to adopt a technology before supporting evidence is available,” the study's authors wrote.

    The CMS hasn't issued a national coverage decision for proton-beam therapy. All local Medicare contractors have approved paying for the treatment.

    In a 2013 Brookings Institution paper, Chandra wrote that the willingness of Medicare to cover the average total cost of proton-beam therapy is incentivizing hospitals to build centers that cost hundreds of millions of dollars and also to “run through as many prostate cancer patients as possible to pay off the bonds.” Other policy experts, writing in the New York Times' opinion page, called proton-beam therapy “crazy medicine and unsustainable public policy.”

    To counter their critics, proton centers are moving forward with studies and clinical trials that they hope will provide data showing that proton-beam therapy is more beneficial for patients. Research conducted by the University of Florida Proton Therapy Institute in Jacksonville and published in March in the International Journal of Radiation Oncology assessed five-year outcomes from three non-randomized trials that followed 211 prostate cancer patients treated with proton-beam therapy. The prospective cohort study, which did not have a comparison arm, claimed the treatment compared favorably with other radiation modalities used to treat prostate cancer.

    While research is underway, some proton center medical directors said they plan to continue to treat patients with early stage prostate cancer, a population that is significantly larger than the number of pediatric or head and neck cancer patients who may benefit from proton therapy. Half of the 750 to 800 patients treated each year at the University of Florida Proton Therapy Institute are prostate cancer patients.

    Other centers such as the Mayo Clinic, which plans to open proton centers in Arizona and Minnesota within the next two years, will not treat low-risk prostate cancer patients. Mayo anticipates that up to 15% of its proton patients will be men with immediate-risk or high-risk prostate cancer, however.

    “We had never planned on treating early stage prostate-cancer patients,” said Dr. Robert Foote, chairman of radiation oncology for Mayo. “A lot of those men don't need any treatment at all.”

    Even centers that plan to offer proton therapy to low-risk prostate-cancer patients said there is a need for data that compares proton therapy to IMRT and brachytherapy, the other radiation methods used to treat prostate cancer.

    Many centers, including a small number of academic medical centers and well-known health systems, are establishing patient registries and participating in clinical trials to make the case to insurers that while the technology is expensive, it may help reduce overall costs and improve patient outcomes in the long run. A randomized clinical trial led by Massachusetts General Hospital in Boston, along with other centers will compare proton-beam therapy to IMRT in 700 patients with low- or intermediate-risk prostate cancer.

    In the interim, some hospitals are looking at installing less costly technology to supply proton-beam radiation. American Shared Hospital Services, a publicly owned company that leases medical equipment to hospitals, inked agreements for centers associated with First Coast Oncology and Orlando Health, both in Florida. The company owns a roughly 1% stake in Mevion Medical Systems, a Littleton, Mass.-based manufacturer of the lowest-cost proton equipment currently available, according to securities filings. Other centers such as the one at Barnes-Jewish Hospital in St. Louis purchased its equipment directly from Mevion.

    The Mevion system's smaller cyclotron costs around $30 million, compared to $150 million to $250 million for a traditional cyclotron. It also takes up significantly less space. However, the Mevion system treats only one patient at a time, compared with the $220 million Scripps center, which has the capacity to treat five patients at a time.

    Regardless of cost, hospitals have a vested interest in ensuring that their centers are successful. While some centers are hundreds of miles from the nearest competitor, other markets will soon be quite crowded.

    Florida, for instance, is slated for three proton centers, which the owners claim are justified by local needs. “We're not trying to be a destination,” said Dr. Scot Ackerman, medical director of First Coast Oncology, a private radiation oncology practice in Jacksonville, Fla. Its proton center will open this year.

    Proponents also agree there is a need for better education and research around proton therapy. At a national conference in late March, a group of proton centers released a model policy that provides a list of indications that they believe insurers should cover, including prostate cancer.

    “It's exciting new technology, but it is costly, so we need to take a measured and reasonable approach and study it in depth and find out if it works or not,” Foote said.

    (This item was updated to correctly identify Blue Shield of California. The article was also updated to indicate Barnes-Jewish Hospital directly purchased its proton system from Mevion Medical Systems, in which American Shared Hospital Services owns an equity interest.)

    Follow Jaimy Lee on Twitter: @MHjlee

    Letter
    to the
    Editor

    Send us a letter

    Have an opinion about this story? Click here to submit a Letter to the Editor, and we may publish it in print.

    Recommended for You
    Mistakes were made in regulation of coronavirus serology tests, FDA officials acknowledge
    Mistakes were made in regulation of coronavirus serology tests, FDA officials acknowledge
    States rush to catch up on delayed vaccines, expand access
    States rush to catch up on delayed vaccines, expand access
    Sponsored Content
    Get Free Newsletters

    Sign up for free enewsletters and alerts to receive breaking news and in-depth coverage of healthcare events and trends, as they happen, right to your inbox.

    Subscribe Today

    The weekly magazine, websites, research and databases provide a powerful and all-encompassing industry presence. We help you make informed business decisions and lead your organizations to success.

    Subscribe
    Connect with Us
    • LinkedIn
    • Twitter
    • Facebook
    • RSS
    • Instagram

    Stay Connected

    Join the conversation with Modern Healthcare through our social media pages

    MDHC_Logotype_white
    Contact Us

    (877) 812-1581

    Email us

     

    Resources
    • Contact Us
    • Advertise with Us
    • Ad Choices Ad Choices
    • Sitemap
    Editorial Dept
    • Submission Guidelines
    • Code of Ethics
    • Awards
    • About Us
    Legal
    • Terms and Conditions
    • Privacy Policy
    • Privacy Request
    Modern Healthcare
    Copyright © 1996-2021. Crain Communications, Inc. All Rights Reserved.
    • News
      • This Week's News
      • COVID-19
      • Providers
      • Insurance
      • Government
      • Finance
      • Technology
      • Safety & Quality
      • People
      • Regional News
        • Midwest
        • Northeast
        • South
        • West
      • Digital Edition
    • Insights
      • ACA 10 Years After
      • Best Practices
      • Special Reports
      • Innovations
    • Transformation
      • Patients
      • Operations
      • Care Delivery
      • Payment
    • Data/Lists
      • Rankings/Lists
      • Interactive Databases
      • Data Points
    • Op-Ed
      • Bold Moves
      • Breaking Bias
      • Commentaries
      • Letters
      • Vital Signs Blog
      • From the Editor
    • Awards
      • Award Programs
        • 100 Most Influential People
        • 50 Most Influential Clinical Executives
        • Best Places to Work in Healthcare
        • Health Care Hall of Fame
        • Healthcare Marketing Impact Awards
        • Top 25 Emerging Leaders
        • Top 25 Innovators
        • Minorities in Healthcare
          • - Luminaries
          • - Top 25 Minority Leaders
          • - Minorities to Watch
        • Women in Healthcare
          • - Luminaries
          • - Top 25 Women Leaders
          • - Women to Watch
      • Nominate
      • Previous Award Programs
        • Excellence in Nursing Awards
        • Design Awards
        • Top 25 COOs in Healthcare
      • Other Award Programs
        • 100 Top Hospitals
        • ACHE Awards
    • Events
      • Conferences
        • Women Leaders in Healthcare Conference
        • Social Determinants of Health Symposium
        • Healthcare Transformation Summit
        • Leadership Symposium
        • Virtual Briefings
          • - Hospital of the Future
          • - Mental Health
          • - Patient Safety & Quality
          • - Strategic Marketing
          • - Virtual Health
          • - Workplace of the Future
      • Galas
        • Best Places to Work Awards Gala
        • Health Care Hall of Fame Gala
        • Top 25 Minority Leaders Gala
        • Top 25 Women Leaders Gala
      • Webinars
      • COVID-19 Event Tracker
    • Listen
      • Podcast - Next Up
      • Podcast - Beyond the Byline
      • Sponsored Podcast - Healthcare Insider
      • Video Series - The Check Up
      • Sponsored Video Series - One on One
    • MORE +
      • Advertise
      • Media Kit
      • Newsletters
      • Jobs
      • People on the Move
      • Reprints & Licensing